Selected research
Industry Research
Embolotherapy Industry Research Report 2026
Market perspective
The global Embolotherapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Embolotherapy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Embolotherapy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Embolotherapy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Embolotherapy market in terms of revenue (US$ million) and, where applicable, service volume (Tons), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Embolotherapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Embolotherapy Market by Company
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Embolotherapy Segment by Type
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Embolotherapy Segment by Application
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Embolotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Embolotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microspheres for Embolization
- Embolism Particles
- Embolic coils
- Liquid Embolic Agent
- Auxiliary Embolization Material
- Others
Applications
- Cancer
- Peripheral Aascular Disease
- Nerve System Disease
- Others
Companies covered
- Medtronic
- Boston Scientific
- Terumo
- Penumbra, Inc.
- Johnson & Johnson
- Sirtex
- Merit Medical
- Varian
- Stryker
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- Cook Medical
- Kaneka
- Meril Life Sciences
- Peijia Medical Limited
- Wallaby Medical
- MicroPort Scientific Corporation
- Shandong Visee Medical Devices Co.,Ltd
- Beijing Taijie Weiye Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Embolotherapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Microspheres for Embolization
- 2.2.3 Embolism Particles
- 2.2.4 Embolic coils
- 2.2.5 Liquid Embolic Agent
- 2.2.6 Auxiliary Embolization Material
- 2.2.7 Others
- 2.3 Embolotherapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 Peripheral Aascular Disease
- 2.3.4 Nerve System Disease
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Embolotherapy Breakdown Data by Type
- 3.1 Global Embolotherapy Historic Market Size by Type (2021-2026)
- 3.2 Global Embolotherapy Forecasted Market Size by Type (2027-2032)
4 Embolotherapy Breakdown Data by Application
- 4.1 Global Embolotherapy Historic Market Size by Application (2021-2026)
- 4.2 Global Embolotherapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Embolotherapy Market Perspective (2021-2032)
- 5.2 Global Embolotherapy Growth Trends by Region
- 5.2.1 Global Embolotherapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Embolotherapy Historic Market Size by Region (2021-2026)
- 5.2.3 Embolotherapy Forecasted Market Size by Region (2027-2032)
- 5.3 Embolotherapy Market Dynamics
- 5.3.1 Embolotherapy Industry Trends
- 5.3.2 Embolotherapy Market Drivers
- 5.3.3 Embolotherapy Market Challenges
- 5.3.4 Embolotherapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Embolotherapy Players by Revenue
- 6.1.1 Global Top Embolotherapy Players by Revenue (2021-2026)
- 6.1.2 Global Embolotherapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Embolotherapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Embolotherapy Head Office and Area Served
- 6.4 Global Embolotherapy Players, Product Type & Application
- 6.5 Global Embolotherapy Manufacturers Established Date
- 6.6 Global Embolotherapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Embolotherapy Market Size (2021-2032)
- 7.2 North America Embolotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Embolotherapy Market Size by Country (2021-2026)
- 7.4 North America Embolotherapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Embolotherapy Market Size (2021-2032)
- 8.2 Europe Embolotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Embolotherapy Market Size by Country (2021-2026)
- 8.4 Europe Embolotherapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Embolotherapy Market Size (2021-2032)
- 9.2 Asia-Pacific Embolotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Embolotherapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Embolotherapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Embolotherapy Market Size (2021-2032)
- 10.2 South America Embolotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Embolotherapy Market Size by Country (2021-2026)
- 10.4 South America Embolotherapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Embolotherapy Market Size (2021-2032)
- 11.2 Middle East & Africa Embolotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Embolotherapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Embolotherapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Medtronic
- 12.1.1 Medtronic Company Information
- 12.1.2 Medtronic Business Overview
- 12.1.3 Medtronic Revenue in Embolotherapy Business (2021-2026)
- 12.1.4 Medtronic Embolotherapy Product Portfolio
- 12.1.5 Medtronic Recent Developments
- 12.2 Boston Scientific
- 12.2.1 Boston Scientific Company Information
- 12.2.2 Boston Scientific Business Overview
- 12.2.3 Boston Scientific Revenue in Embolotherapy Business (2021-2026)
- 12.2.4 Boston Scientific Embolotherapy Product Portfolio
- 12.2.5 Boston Scientific Recent Developments
- 12.3 Terumo
- 12.3.1 Terumo Company Information
- 12.3.2 Terumo Business Overview
- 12.3.3 Terumo Revenue in Embolotherapy Business (2021-2026)
- 12.3.4 Terumo Embolotherapy Product Portfolio
- 12.3.5 Terumo Recent Developments
- 12.4 Penumbra, Inc.
- 12.4.1 Penumbra, Inc. Company Information
- 12.4.2 Penumbra, Inc. Business Overview
- 12.4.3 Penumbra, Inc. Revenue in Embolotherapy Business (2021-2026)
- 12.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
- 12.4.5 Penumbra, Inc. Recent Developments
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Information
- 12.5.2 Johnson & Johnson Business Overview
- 12.5.3 Johnson & Johnson Revenue in Embolotherapy Business (2021-2026)
- 12.5.4 Johnson & Johnson Embolotherapy Product Portfolio
- 12.5.5 Johnson & Johnson Recent Developments
- 12.6 Sirtex
- 12.6.1 Sirtex Company Information
- 12.6.2 Sirtex Business Overview
- 12.6.3 Sirtex Revenue in Embolotherapy Business (2021-2026)
- 12.6.4 Sirtex Embolotherapy Product Portfolio
- 12.6.5 Sirtex Recent Developments
- 12.7 Merit Medical
- 12.7.1 Merit Medical Company Information
- 12.7.2 Merit Medical Business Overview
- 12.7.3 Merit Medical Revenue in Embolotherapy Business (2021-2026)
- 12.7.4 Merit Medical Embolotherapy Product Portfolio
- 12.7.5 Merit Medical Recent Developments
- 12.8 Varian
- 12.8.1 Varian Company Information
- 12.8.2 Varian Business Overview
- 12.8.3 Varian Revenue in Embolotherapy Business (2021-2026)
- 12.8.4 Varian Embolotherapy Product Portfolio
- 12.8.5 Varian Recent Developments
- 12.9 Stryker
- 12.9.1 Stryker Company Information
- 12.9.2 Stryker Business Overview
- 12.9.3 Stryker Revenue in Embolotherapy Business (2021-2026)
- 12.9.4 Stryker Embolotherapy Product Portfolio
- 12.9.5 Stryker Recent Developments
- 12.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
- 12.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
- 12.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
- 12.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Revenue in Embolotherapy Business (2021-2026)
- 12.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
- 12.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
- 12.11 Cook Medical
- 12.11.1 Cook Medical Company Information
- 12.11.2 Cook Medical Business Overview
- 12.11.3 Cook Medical Revenue in Embolotherapy Business (2021-2026)
- 12.11.4 Cook Medical Embolotherapy Product Portfolio
- 12.11.5 Cook Medical Recent Developments
- 12.12 Kaneka
- 12.12.1 Kaneka Company Information
- 12.12.2 Kaneka Business Overview
- 12.12.3 Kaneka Revenue in Embolotherapy Business (2021-2026)
- 12.12.4 Kaneka Embolotherapy Product Portfolio
- 12.12.5 Kaneka Recent Developments
- 12.13 Meril Life Sciences
- 12.13.1 Meril Life Sciences Company Information
- 12.13.2 Meril Life Sciences Business Overview
- 12.13.3 Meril Life Sciences Revenue in Embolotherapy Business (2021-2026)
- 12.13.4 Meril Life Sciences Embolotherapy Product Portfolio
- 12.13.5 Meril Life Sciences Recent Developments
- 12.14 Peijia Medical Limited
- 12.14.1 Peijia Medical Limited Company Information
- 12.14.2 Peijia Medical Limited Business Overview
- 12.14.3 Peijia Medical Limited Revenue in Embolotherapy Business (2021-2026)
- 12.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
- 12.14.5 Peijia Medical Limited Recent Developments
- 12.15 Wallaby Medical
- 12.15.1 Wallaby Medical Company Information
- 12.15.2 Wallaby Medical Business Overview
- 12.15.3 Wallaby Medical Revenue in Embolotherapy Business (2021-2026)
- 12.15.4 Wallaby Medical Embolotherapy Product Portfolio
- 12.15.5 Wallaby Medical Recent Developments
- 12.16 MicroPort Scientific Corporation
- 12.16.1 MicroPort Scientific Corporation Company Information
- 12.16.2 MicroPort Scientific Corporation Business Overview
- 12.16.3 MicroPort Scientific Corporation Revenue in Embolotherapy Business (2021-2026)
- 12.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
- 12.16.5 MicroPort Scientific Corporation Recent Developments
- 12.17 Shandong Visee Medical Devices Co.,Ltd
- 12.17.1 Shandong Visee Medical Devices Co.,Ltd Company Information
- 12.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
- 12.17.3 Shandong Visee Medical Devices Co.,Ltd Revenue in Embolotherapy Business (2021-2026)
- 12.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
- 12.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
- 12.18 Beijing Taijie Weiye Technology
- 12.18.1 Beijing Taijie Weiye Technology Company Information
- 12.18.2 Beijing Taijie Weiye Technology Business Overview
- 12.18.3 Beijing Taijie Weiye Technology Revenue in Embolotherapy Business (2021-2026)
- 12.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
- 12.18.5 Beijing Taijie Weiye Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst